Clinical Autonomic Research

, Volume 16, Issue 2, pp 90–97 | Cite as

A world without pain or tears*



The world of the child with familial dysautonomia (FD), a genetic disorder affecting development of the sensory and autonomic nervous system, is not idyllic. However, over the last 35 years advances in supportive treatments have improved morbidity and mortality. Recent genetic breakthroughs have further expanded thinking about this disorder and suggested innovative approaches to modifying genetic expression. This article reviews the current supportive treatment modalities and their rationale, as well as the suggested new treatments that may alter the function and prognosis of an individual affected with FD.

Key words

Familial dysautonomia (FD) hereditary sensory and autonomic neuropathy (HSAN) type 3 IKBKAP 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aguayo AJ, Nair CPV, Bray GM (1971) Peripheral nerve abnormalities in the Riley-Day syndrome, findings in sural nerve biopsy. Arch Neurol 24:106–116PubMedGoogle Scholar
  2. 2.
    Anderson SL, Coli R, Daly IW, Kichula EA, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations in the IKAP gene. Am J Hum Genet 68:753–758CrossRefPubMedGoogle Scholar
  3. 3.
    Anderson SL, Qiu J, Rubin BY (2003) Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biophys Res Commun 306:303–309CrossRefPubMedGoogle Scholar
  4. 4.
    Anderson SL, Qiu J, Rubin BY (2003) EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem Biophys Res Commun 310(2):627–633CrossRefPubMedGoogle Scholar
  5. 5.
    Axelrod FB (1996) Autonomic and Sensory Disorders. In: Emory AEH, Rimoin DL (eds) Principles and practice of medical genetics, 3rd ed. Churchill Livingstone, Edinburgh, pp 397–411Google Scholar
  6. 6.
    Axelrod FB (2002) Hereditary sensory and autonomic neuropathies: familial dysautonomia and other HSANs. Clin Auton Res12(Suppl 1):2–14CrossRefGoogle Scholar
  7. 7.
    Axelrod FB (2004) Familial Dysautonomia (Invited Review). Muscle Nerve 29:352–363CrossRefPubMedGoogle Scholar
  8. 8.
    Axelrod FB (2005) Familial dysautonomia: A review of the current pharmacological treatments. Expert Opin. Pharmocother 6:561–567CrossRefGoogle Scholar
  9. 9.
    Axelrod FB, Glickstein JS, Weider J, Gluck MC, Friedman D (1993) The effects of postural change and exercise on renal haemodynamics in familial dysautonomia. Clin Auton Res 3:195–200CrossRefPubMedGoogle Scholar
  10. 10.
    Axelrod FB, Goldberg JD, Ye XY, Maayan C (2002) Survival in familial dysautonomia: Impact of early intervention. J Pediatr 141:518–523CrossRefPubMedGoogle Scholar
  11. 11.
    Axelrod FB, Goldberg JD, Rolnitzky L, Mull J, Mann SP, Gold von Simson G, Berlin D, Slaugenhaupt SA (2005) Fludrocortisone in patients with familial dysautonomia: Assessing effect on clinical parameters and gene expression. Clin Auton Res 15:284–291CrossRefPubMedGoogle Scholar
  12. 12.
    Axelrod FB, Goldstein DS, Holmes C, Berlin D, Kopin I (1996) Pattern of plasma catechols in familial dysautonomia. Clin Auton Res 6:205–209CrossRefPubMedGoogle Scholar
  13. 13.
    Axelrod FB, Gouge TH, Ginsburg HB, Bangaru BS, Hazzi C (1991) Fundoplication and gastrostomy in familial dysautonomia. J Pediatr 118:388–394CrossRefPubMedGoogle Scholar
  14. 14.
    Axelrod FB, Iyer K, Fish I, Pearson J, Sein ME, Spielholz N (1981) Progressive sensory loss in familial dysautonomia. Pediatrics 65:517–522Google Scholar
  15. 15.
    Axelrod FB, Krey L, Glickstein JS, Freidman D, Weider J, Metakis L, Porges VM, Mineo M, Notterman (1994) Atrial natriuretic peptide and catecholamine response to orthostatic hypotension and treatments in familial dysautonomia. Clin Auton Res 4:311–318CrossRefPubMedGoogle Scholar
  16. 16.
    Axelrod FB, Krey L, Glickstein JS, Weider-Allison J, Friedman D (1995) Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia. J Auton Nerv System 55:29–35CrossRefGoogle Scholar
  17. 17.
    Axelrod FB, Maayan Ch (1999) Familial dysautonomia. In: Burg FD, Ingelfinger JR, Wald ER, Polin RA (eds) Gellis and Kagen’s current pediatric therapy, 16th ed. WB Saunders, Philadelphia, pp 466–469Google Scholar
  18. 18.
    Axelrod FB, Nachtigall R, Dancis J (1974) Familial dysautonomia: diagnosis pathogenesis and management. In: Schulman I (ed) Advances in pediatrics, Vol 21. Yearbook, Chicago, pp 75–96Google Scholar
  19. 19.
    Axelrod FB, Pearson J (1984) Congenital sensory neuropathies. Diagnostic distinction from familial dysautonomia. Am J Dis Child 138:947–954PubMedGoogle Scholar
  20. 20.
    Axelrod FB, Porges RF, Sein ME (1987) Neonatal recognition of familial dysautonomia. J Pediatr 110:946–948CrossRefPubMedGoogle Scholar
  21. 21.
    Axelrod FB, Putman D, Berlin D, Rutkowski M (1997) Electrocardiographic measures and heart rate variability in patients with familial dysautonomia. Cardiology 88:133–140PubMedGoogle Scholar
  22. 22.
    Axelrod FB, Schneider KM, Ament ME, Kutin ND, Fonkalsrud EW (1982) Gastroesophageal fundoplication and gastrostomy in familial dysautonomia. Ann Surg 195:253–258PubMedGoogle Scholar
  23. 23.
    Axelrod FB, Solomon J, D’Amico R (2000) Familial dysautonomia. In: Fraunfelder FT, Hampton Roy F (eds) Current ocular therapy, 5th edition. WB Saunders, Philadelphia, pp 285–288Google Scholar
  24. 24.
    Axelrod FB, Zupanc M, Hilz MJ, Kramer EL (2000) Ictal SPECT during autonomic crisis in familial dysautonomia. Neurology 55:122–125PubMedGoogle Scholar
  25. 25.
    Bernardi L, Hilz M, Stemper B, Passino C, Welsch G, Axelrod FB (2002) Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia. Am J Respir Crit Care Med 167:141–149CrossRefPubMedGoogle Scholar
  26. 26.
    Brunt PW, McKusick VA (1970) Familial dysautonomia, a report of genetic and clinical studies,with a review of the literature. Medicine (Baltimore) 49:343–374PubMedGoogle Scholar
  27. 27.
    Cuajungco MP, Leyne M, Gill SP, Mull J, Lu W, Zagzag D, Axelrod FB, Gusella JF, Maayan Ch, Slaugenhaupt SA (2003) Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 72:749–758CrossRefPubMedGoogle Scholar
  28. 28.
    Clayson D, Welton W, Axelrod FB (1980) Personality development and familial dysautonomia. Pediatrics 65:269–274PubMedGoogle Scholar
  29. 29.
    Dancis, J (1968) Altered drug responses in familial dysautonomia. Ann NY Acad Sci 151:876–879PubMedGoogle Scholar
  30. 30.
    Dancis J, Smith AA (1966) Familial dysautonomia. N Engl J Med 274:207–209PubMedCrossRefGoogle Scholar
  31. 31.
    Diamond GA, D’Amico RA, Axelrod FB (1987) Optic nerve dysfunction in familial dysautonomia. Am J Ophthalmol 104:645–648PubMedGoogle Scholar
  32. 32.
    Dong J, Edelmann L, Bajwa AM, Kornreich R, Desnick R (2002) Familial dysautonomia: detection of the IKBKAP IVS20+6→C and R696P mutations and frequencies among Ashkenazi Jews. Am J Med Genet 110:253–257CrossRefPubMedGoogle Scholar
  33. 33.
    Dyck PJ (1993) Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 1065–1093Google Scholar
  34. 34.
    Dyck P, Kawamura Y, Low PA, Shimono M (1978) The numbers and sizes of reconstructed peripheral anatomic sensory and motor neurons in a case of dysautonomia. J Neuropathol Exp Neurol 37:741–755PubMedGoogle Scholar
  35. 35.
    Edelman NH, Cherniack NS, Lahiri S, Richards E, Fishman AP (1970) The effects of abnormal sympathetic nervous function upon the ventilatory response to hypoxia. J Clin Invest 41:1153–1165Google Scholar
  36. 36.
    Filler J, Smith AA, Stone S, Dancis J (1965) Respiratory control in familial dysautonomia. J Pediatr 66:509–516CrossRefPubMedGoogle Scholar
  37. 37.
    Freedman AM, Helme W, Havel J, Eustis MJ, Riley C, Langford WS (1957) Psychiatric aspects of familial dysautonomia. Am J Orthopsychiatry 27:96–106PubMedCrossRefGoogle Scholar
  38. 38.
    Gadoth N, Sokol J, Lavie P (1983) Sleep structure and nocturnal disordered breathing in familial dysautonomia. J Neurol Sci 60:117–125CrossRefPubMedGoogle Scholar
  39. 39.
    Gold-von Simson G, Rutkowski M, Berlin D, Axelrod FB (2005) Pacemakers in patients with familial dysautonomia. A review of experience with 20 patients. Clin Auto Res 15:15–20CrossRefGoogle Scholar
  40. 40.
    Goldstein DS, Moak J, Pechnik S, Holmes C, Axelrod F (2005) Cardiac sympathetic innervation in familial dysautonomia. Clin Aut Res 15:284–291CrossRefGoogle Scholar
  41. 41.
    Goodall G, Gitlow SE, Alton H (1971) Decreased noradrenaline synthesis in FDJ Clin Invest 50:2734–2740Google Scholar
  42. 42.
    Grover-Johnson N, Pearson J (1976) Deficient vascular innervation in familial dysautonomia, an explanation for vasomotor instability. J Neuropath Appl Neurobiol 2:217–224CrossRefGoogle Scholar
  43. 43.
    Gyepes MT, Linde LM (1968) Familial dysautonomia: the mechanism of aspiration. Radiology 91:471–475Google Scholar
  44. 44.
    Hilz MJ, Kolodny EH, Neuner I, Stemper B, Axelrod FB (1998) Highly abnormal thermotest in familial dysautonomia suggests increased cardiac autonomic risk. J Neurol Neurosurg Psychiatry 65:338–343PubMedCrossRefGoogle Scholar
  45. 45.
    Hilz MJ, Axelrod FB, Schweibold G, Kolodny EH (1999) Sympathetic skin response following thermal, electrical, acoustic and inspiratory gasp stimulation in familial dysautonomia patients and healthy persons. Clin Auton Res 9:165–177CrossRefPubMedGoogle Scholar
  46. 46.
    Hilz MJ, Axelrod FB, Steingrueber M, Stemper B (2002) Valsalva maneuver suggests increased rigidity of cerebral resistance vessels in familial dysautonomia. Clin Auton Res12:385–392CrossRefPubMedGoogle Scholar
  47. 47.
    Hilz MJ, Axelrod FB, Sauer P, Russo H, Heckman JG, Neundorfer B (1997) TCD in familial dysautonomia patients shows impaired cerebral autoregulation and paradoxic cerebral vasoconstriction during head-upright tilt. J Neuroimaging 7:240Google Scholar
  48. 48.
    Krausz Y, Maayan Ch, Faber J, Marciano R, Mogle P, Wynchank S (1994) Scintigraphic evaluation of esophageal transit and gastric emptying in familial dysautonomia. J Radiol 18:52–56CrossRefGoogle Scholar
  49. 49.
    Kroop IG (1956) The production of tears in familial dysautonomia: preliminary report. J Pediatr 58:328–329Google Scholar
  50. 50.
    Leyne M, Mull J, Gill SP, Cuajungco MP, Oddoux C, Blumenfeld A, Maayan Ch, Gusella JF,Axelrod FB, Slaugenhaupt SA (2003) Identification of the first non-Jewish mutation in familial dysautonomia Am J Med Genet 118A:305–308CrossRefPubMedGoogle Scholar
  51. 51.
    Liebman SD (1956) Ocular manifestations of Riley-Day syndrome. Arch Ophthalmol 56:719–725Google Scholar
  52. 52.
    Maayan Ch, Carley DW, Axelrod FB, Grimes J, Shannon DC (1992) Respiratory system stability and abnormal carbon dioxide homeostasis. J Appl Physiol 72:1186–1193CrossRefPubMedGoogle Scholar
  53. 53.
    Margulies SI, Brunt PW, Silbiger ML (1968) Familial dysautonomia: a cineradiographic study of the swallowing mechanism. Radiology 90:107–112PubMedGoogle Scholar
  54. 54.
    Mason DT, Kopin IJ, Braunwald E (1966) Abnormalities in reflex control of the circulation in familial dysautonomia. Am J Med 41:898–909CrossRefPubMedGoogle Scholar
  55. 55.
    Pearson J, Axelrod FB, Dancis J (1974) Current concepts of dysautonomia: neurological defects. Ann NY Acad Sci 228:288–300PubMedGoogle Scholar
  56. 56.
    Pearson J, Brandeis L, Goldstein M (1979) Tyrosine hydroxylase immunohistoreactivity in familial dysautonomia. Science 206:71–72PubMedGoogle Scholar
  57. 57.
    Pearson J, Brandeis L, Cuello AC (1982) Depletion of substance P-containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 295:61–63CrossRefPubMedGoogle Scholar
  58. 58.
    Pearson J, Gallo G, Gluck M, Axelrod F (1980) Renal disease in familial dysautonomia. Kidney Int 17:102–112PubMedGoogle Scholar
  59. 59.
    Pearson J, Pytel, B (1978) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 39:47–59CrossRefPubMedGoogle Scholar
  60. 60.
    Pearson J, Pytel B (1978) Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. J Neurol Sci 39:123–130CrossRefPubMedGoogle Scholar
  61. 61.
    Pearson J, Pytel B, Grover-Johnson N, Axelrod FB, Dancis J (1978) Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia. J Neurol Sci 35:77–97CrossRefPubMedGoogle Scholar
  62. 62.
    Riley CM, Day RL, McL Greeley D, Langford WS (1949) Central autonomic dysfunction with defective lacrimation. Report of 5 cases. Pediatrics 3:468–477PubMedGoogle Scholar
  63. 63.
    Slaugenhaupt SA Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungo MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598–605CrossRefPubMedGoogle Scholar
  64. 64.
    Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims M, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13(4):429–436CrossRefPubMedGoogle Scholar
  65. 65.
    Smith AA, Dancis J (1963) Physiologic studies in familial dysautonomia. J Pediatr 63:838–840CrossRefGoogle Scholar
  66. 66.
    Smith AA, Dancis J (1963) Response to intradermal histamine in familial dysautonomia: a diagnostic test. J Pediatr 63:889–894CrossRefPubMedGoogle Scholar
  67. 67.
    Smith AA, Dancis J (1964) Peripheral sensory deficits in familial dysautonomia. J Pediatr 65:1035CrossRefGoogle Scholar
  68. 68.
    Smith AA, Dancis J (1964) Exaggerated response to infused norepinephrine in familial dysautonomia. N Engl J Med 270:704–707PubMedCrossRefGoogle Scholar
  69. 69.
    Smith AA, Dancis J, Breinin G (1965) Ocular responses to autonomic drugs in familial dysautonomia. Invest Ophthalmol 4:358–361PubMedGoogle Scholar
  70. 70.
    Smith AA, Dancis J (1967) Catecholamine release in familial dysautonomia. N Engl J Med 277:61–64PubMedCrossRefGoogle Scholar
  71. 71.
    Smith AA, Taylor T, Wortis SB (1963) Abnormal catecholamine metabolism in familial dysautonomia. N Engl J Med 268:705–707PubMedCrossRefGoogle Scholar
  72. 72.
    Smith AA, Hirsch JI, Dancis J (1965) Responses to infused methacholine in familial dysautonomia. Pediatrics 36:225–230PubMedGoogle Scholar
  73. 73.
    Smith AA, Farbman A, Dancis J (1965) Absence of taste bud papillae in familial dysautonomia. Science 147:1040–1041PubMedGoogle Scholar
  74. 74.
    Sugarman EA, Allitto BA (2002) Familial dysautonomia mutation frequency: clinical testing of greater than 2700 specimens confirms high frequency in Ashkenazi Jews. Am J Hum Genet 71(Suppl):387Google Scholar
  75. 75.
    Udassin R, Seror D, Vinograd I, Zamir O, Godfrey S, Nissan S (1992) Nissen fundoplication in the treatment of children with familial dysautonomia. Am J Surg 164:332–336PubMedGoogle Scholar
  76. 76.
    Welton W, Clayton D, Axelrod F, Levine D (1979) Intellectual development in familial dysautonomia. Pediatrics 63:708–712PubMedGoogle Scholar
  77. 77.
    Ziegler MG, Lake RC, Kopin IJ (1976) Deficient sympathetic nervous system response in familial dysautonomia. N Engl J Med 294:630–633PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Dysautonomia Treatment and Evaluation CenterNYU Medical CenterNew York (NY) 10016USA

Personalised recommendations